No More Grey Area: Digital Health Law Ushers in New Era

For over a decade, the conversation surrounding digital health in Mexico has been dominated by a single, persistent theme: potential restricted by uncertainty. We have seen pilots, isolated efforts, and a booming private ecosystem of startups pushing the boundaries of what is possible. Yet, the lack of a comprehensive legal framework created a "grey area" that often stalled large-scale investment and adoption, particularly within the public sector.

That era effectively ended on Jan. 15, 2026.

With the publication of the latest decree reforming the General Health Law (LGS) in the Official Gazette of the Federation, Mexico has not just updated its regulations; it has fundamentally altered the operating system of its national healthcare. For industry leaders, investors, and policymakers, this is no longer about if digital transformation will happen, but how we will comply with its new, mandatory reality.

The Digital Mandate: From Option to Obligation

The headline of this reform is undoubtedly the addition of Chapter VI BIS, dedicated entirely to digital health. The law now explicitly defines concepts that were previously loose terms: digital health, telehealth, telemedicine, and electronic health records are now codified legal entities.

However, the game-changer lies in the language used. The reform does not merely "suggest" the adoption of these technologies. It mandates that the Ministry of Health issue provisions for their "implementation, supervision, and continuous improvement" across all public institutions of the National Health System. This includes giants like IMSS, ISSSTE, and the newly consolidated IMSS-Bienestar.

For the private sector, this signals a massive opening. The government is legally bound to integrate infrastructure, training, and protocols for remote care . This will inevitably drive public tenders and public-private partnerships focused on software, cybersecurity, and interoperability solutions. The message is clear: the state is moving to the cloud, and it needs the private sector to build the ladder.

Big Data: The Legal Foundation for AI

Perhaps the most forward-thinking aspect of the decree is found in Article 71 Ter. In a move that puts Mexico ahead of many Latin American peers, the law explicitly recognizes the analysis of "large volumes of data" (big data) as a core purpose of digital health.

The objective is defined as identifying patterns, optimizing diagnoses, and — crucially — personalizing treatments. This is the "green light" the pharmaceutical and tech industries have been waiting for. Until now, the use of secondary data for predictive analytics faced ambiguous privacy hurdles. While data protection laws still apply, the LGS now validates the utility of this data for health intelligence. This provides the necessary legal grounding to deploy artificial intelligence and machine learning models at a national scale, transforming passive archives into active tools for preventive medicine.

Interoperability and the 'Master Plan'

The reform also tackles the historic fragmentation of the Mexican health system. The concept of a "unique and shared" medical record is reinforced by new mandates for interoperability. The law obliges institutions to digitalize patient information specifically to facilitate "secure data exchange" between professionals and establishments.

However, this integration comes with a new gatekeeper. The decree strengthens the National Master Plan for Health Infrastructure and High-Tech Medical Equipment. Moving forward, any project to create medical units or acquire high-tech equipment must have a registration folio in this Master Plan to receive funding.

For market access teams, this is a critical pivot point. Selling advanced medical devices or infrastructure to the government will now require strict alignment with this centralized planning instrument. It is a move towards efficiency, but it also adds a layer of bureaucratic complexity that companies must navigate strategically.
 

A Nod to National Industry: The 'Nearshoring' Effect

Beyond technology, the reform introduces a significant industrial policy shift that aligns with the broader "nearshoring" trend. A modification to Article 10 establishes a clear preference in consolidated procurement processes.

The Ministry of Health is now instructed to promote the participation of companies — national or international — that can prove they have investment in national territory. This applies to factories, laboratories, and warehouses that are part of the production chain, as well as companies conducting scientific research within Mexico.

This is a subtle but powerful message to the pharmaceutical and medtech industries: having a commercial office is no longer enough. To secure a privileged position in government purchasing, the state expects a physical footprint. This aims to secure supply chains and boost local economic development, rewarding those who bet on Mexico with tangible infrastructure.
 

The Road Ahead: The 180-Day Sprint

While the publication of the law is a milestone, the heavy lifting begins now. The decree establishes a period of 180 days for the Ministry of Health to integrate the information for the Master Plan and issue the necessary secondary regulations.

We are entering a semester of intense regulatory definition. The "what" is decided; the "how" is up for grabs. As an industry, we must move from a stance of lobbying for certainty to one of active collaboration in implementation.

Jan. 15, 2026, marks the definitive moment when Mexico’s health sector finally aligned with digital reality. We now possess a framework that is modern, ambitious, and mandatory. For those of us dedicated to transforming healthcare, the tools are finally on the table. It is time to build.